← back to search

Yuejin Li

Sun Yat-sen University Cancer Center · CN
Area of research
Materials Chemistry · Catalysis
Research interest
Research interests include Cancer research, Metastasis, Medicine, Biology, Hepatocellular carcinoma, and Oncogene.
h-index
citations
925
works
12
NIH funding
primary concept
email

Recent publications

METTL3-mediated methylation of RAC2 contributes to cell motility, oxidative stress and inflammation in TNF‐α-stimulated rheumatoid arthritis fibroblast-like synovial cells
Journal of Orthopaedic Surgery and Research 2025cited by 9position: middledoi
Silica modulated palladium catalyst with superior activity for the selective catalytic reduction of nitrogen oxides with hydrogen
Applied Catalysis B: Environmental 2023cited by 28position: middledoi
Colloidal Platinum–Copper Nanocrystal Alloy Catalysts Surpass Platinum in Low-Temperature Propene Combustion
Journal of the American Chemical Society 2022cited by 57position: middledoi
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
Cancer Letters 2018cited by 142position: middledoi
RETRACTED ARTICLE: Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis
Cell Death and Disease 2017cited by 76position: middledoi
FCN2 inhibits epithelial–mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling
Cancer Letters 2016cited by 85position: middledoi
N‐myc downstream‐regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA‐181c negative feedback pathway
Hepatology 2016cited by 44position: middledoi
YAP is a critical oncogene in human cholangiocarcinoma
Oncotarget 2015cited by 150position: middledoi
Selecting molecular therapeutic drug targets based on the expression profiles of intrahepatic cholangiocarcinomas and miRNA-mRNA regulatory networks
Oncology Reports 2015cited by 3position: middledoi
Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis
Hepatology 2014cited by 129position: middledoi
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma
Molecular Cancer 2014cited by 61position: middledoi
Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation
American Journal of Physiology-Heart and Circulatory Physiology 2014cited by 49position: middledoi
Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma
Hepatology 2013cited by 101position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yingjian Liang · Harbin Medical University8 papers (2013–2018)Jiabei Wang · Queen's University8 papers (2013–2018)Tongsen Zheng · Harbin Medical University8 papers (2013–2018)Boshi Sun · Ministry of Education of the People's Republic of China7 papers (2013–2018)Dalong Yin · Ministry of Education of the People's Republic of China6 papers (2013–2016)Huawen Shi · Harbin Medical University6 papers (2014–2018)Shangha Pan · Ministry of Education of the People's Republic of China6 papers (2013–2016)Hongchi Jiang · Nanjing University of Chinese Medicine5 papers (2013–2016)Ruipeng Song · Ministry of Education of the People's Republic of China5 papers (2013–2016)Changming Xie · Sun Yat-sen University5 papers (2013–2016)Lianxin Liu · Shandong University of Technology5 papers (2013–2016)Tiemin Pei · Ministry of Education of the People's Republic of China4 papers (2013–2015)Xuan Song · Guizhou Provincial People's Hospital4 papers (2013–2016)Guangchao Yang · Harbin Medical University4 papers (2014–2016)Shuyi Qi · Harbin Medical University3 papers (2013–2014)Zhao‐Yang Lu · Harbin Medical University3 papers (2013–2016)Xianzhi Meng · Harbin Medical University2 papers (2014–2014)Huanlai Wang · Harbin Medical University2 papers (2015–2016)Mingxi Zhu · Harbin Medical University2 papers (2016–2016)Jia Liu · Harbin Medical University2 papers (2013–2014)